You are currently viewing the summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Summary
A key reason the HIV vaccine search has struggled for nearly 30 years is because so many variants of the virus exist that it easily dodges antibody attack. But recently, researchers have discovered highly potent antibodies that work against more than 100 HIV variants. Intensive efforts are now under way to design vaccines that can stimulate the immune system to produce high levels of these so-called broadly neutralizing antibodies.
